Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Nivagen Pharmaceuticals Inc

US Class II Terminated · initiated 2024-09-24

Presence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg…

Glenmark Pharmaceuticals Inc., USA

US Class II Ongoing · initiated 2024-09-24

Defective Delivery System: The dip tube is clogged causing the spray not to work.

VIONA PHARMACEUTICALS INC

US Class II Ongoing · initiated 2024-09-24

Crystallization

Advanced Accelerator Applications USA, Inc.

US Class II Ongoing · initiated 2024-09-23

CGMP deviations

Gilead Sciences, Inc.

US Class I Terminated · initiated 2024-09-19

Presence of Particulate Matter: Presence of glass particle.

EnviroServe Chemicals Inc.

US Class II Ongoing · initiated 2024-09-18

CGMP deviations

123Herbals

US Class I Ongoing · initiated 2024-09-18

Marketed without an approved NDA/ANDA: Product found to be tainted with undeclared dexamethasone and chlorpheniramine.

Bionpharma Inc.

US Class I Terminated · initiated 2024-09-17

Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.

AbbVie Inc.

US Class II Ongoing · initiated 2024-09-16

Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.

AbbVie Inc.

US Class II Ongoing · initiated 2024-09-16

Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.

Refresh Lacri-Lube Ophthalmic ointment

Canada Type II Ongoing · initiated 2024-09-16

Product quality. Do not use the affected product. Return it to your local pharmacy for proper disposal.Seek medical attention if you have used this product and …

Panhematin 268 mg/vial powder for solution

Canada Type I Ongoing · initiated 2024-09-13

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Mckesson Medical-Surgical Inc. Corporate Office

US Class II Terminated · initiated 2024-09-11

Temperature abuse: Products exposed to improper temperature above drug label specifications.

Zhejiang Jingwei Pharmaceutical Co., Ltd.

US Class II Ongoing · initiated 2024-09-11

Incorrect/Undeclared Excipients: The inactive ingredients labeled on the product boxes and tubes are listed as "mineral oil , petrolatum ". The inactive ingredi…

Mckesson Medical-Surgical Inc. Corporate Office

US Class II Terminated · initiated 2024-09-11

cGMP Deviations: Temperature excursion

Jamp Telmisartan-HCT tablet

Canada Type II Ongoing · initiated 2024-09-11

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

AG Telmisartan-HCT Tablet

Canada Type II Ongoing · initiated 2024-09-11

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Vitamin D3 10000 unit tablet

Canada Type II Ongoing · initiated 2024-09-09

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Jamp-Acetaminophen 325 mg & 500 mg tablet

Canada Type II Ongoing · initiated 2024-09-09

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Jamp-Telmisartan 40 mg & 80 mg tablet

Canada Type II Ongoing · initiated 2024-09-09

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

AG-Telmisartan 40 mg & 80 tablet

Canada Type II Ongoing · initiated 2024-09-09

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

JAMP-Clopidogrel

Canada Type I Ongoing · initiated 2024-09-06

Product quality. Verify if your product is affected.Contact the recalling firm if you have any questions about the recall.Report any health product related side…

AG-Clopidogrel

Canada Type I Ongoing · initiated 2024-09-06

Product quality. Verify if your product is affected.Contact the recalling firm if you have any questions about the recall.Report any health product related side…

JAMP-Pyridostigmine Bromide 60 mg tablets

Canada Type II Ongoing · initiated 2024-09-06

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

MJ Tonic Nigelle nasal drops

Canada Type II Ongoing · initiated 2024-09-06

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…